Shandong Wit Dyne Health Co Ltd
000915
Company Profile
Business description
Shandong Wit Dyne Health Co Ltd is engaged in the pharmaceutical industry. The product portfolio includes Azithromycin Granules, Rosiglitazone Tartrate Tablets, Lanso (roxithromycin), Yi Kexin-over 1 year old among others.
Contact
No. 17703, Jingshi Road
4th Floor, Walter Plaza
Shandong Province
Jinan250061
CHNT: +86 53185198090
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2026
Employees
1,759
Stocks News & Analysis
stocks
Strong guidance from undervalued ASX share
Shares surged after the announcement of first half fiscal 2026 guidance.
stocks
TSMC earnings: Refining guidance and expansion plans amid strong AI demand
We maintain our fair value estimate for TSMC stock.
stocks
Unconventional wisdom: A top performing ‘AI share’ accidently ended up in my portfolio
Trying to make sense of a share caught up in irrational exuberance.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,168.70 | 33.00 | 0.36% |
| CAC 40 | 8,287.74 | 25.04 | 0.30% |
| DAX 40 | 24,235.14 | 80.67 | 0.33% |
| Dow JONES (US) | 48,578.72 | 115.00 | 0.24% |
| FTSE 100 | 10,574.49 | 15.50 | -0.15% |
| HKSE | 26,160.33 | 233.93 | -0.89% |
| NASDAQ | 24,102.70 | 86.69 | 0.36% |
| Nikkei 225 | 58,475.90 | 1,042.44 | -1.75% |
| NZX 50 Index | 12,905.67 | 160.39 | -1.23% |
| S&P 500 | 7,041.28 | 18.33 | 0.26% |
| S&P/ASX 200 | 8,946.90 | 36.80 | 0.41% |
| SSE Composite Index | 4,051.43 | 4.12 | -0.10% |